ClinicalTrials.Veeva

Menu

Motivational Interviewing to Prevent Suicide in High Risk Veterans

VA Office of Research and Development logo

VA Office of Research and Development

Status

Completed

Conditions

Suicidal Ideation
Treatment Engagement

Treatments

Other: TAU Alone
Behavioral: MI-SI+TAU
Behavioral: MI-SI-R+TAU

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT01544127
MHBA-20-11S
IK2CX00064 (Other Grant/Funding Number)

Details and patient eligibility

About

The purpose of study is to test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high risk for suicide.

Full description

Veterans who receive health care from the VA are at elevated risk for suicide, and the number of Veterans at high risk may be growing. Although the months following discharge from psychiatric hospitalization are a period of acute risk for Veterans, there is a dearth of empirically supported treatments tailored to psychiatric inpatients and no studies examining treatments for psychiatrically hospitalized Veterans. This randomized controlled trial will test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at the Syracuse VA Medical Center. To meet high-risk criteria, Veterans must score over two on the Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by suicide. Participants will complete a screening assessment to confirm eligibility and a baseline assessment of risk factors for suicide. They will be randomized to receive Motivational Interviewing to Address Suicidal Ideation (MI-SI) or a revised version (MI-SI-R) plus treatment as usual (TAU), or TAU alone. The MI-SI groups will receive two sessions of MI-SI during hospitalization and one telephone booster session after discharge. Participants in all conditions will be asked to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in the severity of suicidal ideation will be measured using the SSI.

Enrollment

132 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Veteran status,
  • admitted to psychiatric inpatient unit,
  • age 18 and over,
  • English speaking,
  • able to understand the study and provide informed consent,
  • clinically cleared to participate by unit staff,
  • receive health care from a VHA facility in upstate New York
  • at increased risk for suicide (Scale for Suicidal Ideation [SSI] > 2)

Exclusion criteria

  • current psychosis,
  • current mania,
  • dementia,
  • prisoner status,
  • being inaccessible
  • being discharged from the unit less than 48 hours after being identified by study staff

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

132 participants in 3 patient groups

MI-SI+TAU
Experimental group
Description:
Motivational Interviewing to Address Suicidal Ideation
Treatment:
Behavioral: MI-SI+TAU
MI-SI-R+TAU
Experimental group
Description:
Motivational Interviewing to Address Suicidal Ideation Revised
Treatment:
Behavioral: MI-SI-R+TAU
TAU Alone
Other group
Description:
Treatment as usual
Treatment:
Other: TAU Alone

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems